Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment
- PMID: 32475056
- PMCID: PMC7300759
- DOI: 10.1111/dth.13706
Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment
Conflict of interest statement
The authors declare no potential conflict of interest.
Comment in
-
Comment on "Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment".Dermatol Ther. 2020 Nov;33(6):e13840. doi: 10.1111/dth.13840. Epub 2020 Jul 6. Dermatol Ther. 2020. PMID: 32536009 Free PMC article. No abstract available.
Comment on
-
The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience.Br J Dermatol. 2020 Aug;183(2):373-374. doi: 10.1111/bjd.19158. Epub 2020 May 28. Br J Dermatol. 2020. PMID: 32343839 Free PMC article. No abstract available.
References
-
- Li C, Xu BH. The viral, epidemiologic, clinical characteristics and potential therapy options for COVID‐19: a review. Eur Rev Med Pharmacol Sci. 2020;24(8):4576‐4584. - PubMed
-
- Riccardo F, Andrianou X, Bella A, Del Manso M, Urdiales AM, Fabiani M, et al. For Istituto Superiore di Sanità. 7th May 2020. Retrieved by https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino‐sorveglia... (last accessed May 14 2020).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
